Lataa...
New Medications in the Treatment of Hereditary Transthyretin Amyloidosis
Hereditary transthyretin amyloidosis is an inherited disorder that results in the gradual progressive deposit of abnormal protein called amyloid in the body’s organs and tissues. There are currently no approved drugs to treat transthyretin amyloidosis, and patients may require liver transplantation...
Tallennettuna:
| Julkaisussa: | Hosp Pharm |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6050879/ https://ncbi.nlm.nih.gov/pubmed/30038442 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0018578718779757 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|